Esposito, S; Cohen, R; Domingo, JD et al.
Do We Know When, What and For How Long to Treat? Antibiotic Therapy for Pediatric Community-acquired PneumoniaPEDIATRIC INFECTIOUS DISEASE JOURNAL. Bd. 31. H. 6. 2012 S. E78-E85
Schmeh, I; Ziesel, B; Schwind, M et al.
Dunndarmvolvulus infolge eines mesenterialen zystischen Lymphangioms beim Neugeborenen [Abstract]Monatsschr Kinderheilkd. Bd. 160. H. Spl1. 2012 S. 175
Richter, Steffen; Hueckstaedt, Thomas; Aksakal, Devrim et al.
Embolism Risk Analysis-Helium Versus Carbon DioxideJOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES. Bd. 22. H. 8. 2012 S. 824-829
Wagner, N.; Zepp, F.
Emergencies in Childhood and Adolescence New Section for Monatsschritt KinderheilkundeMONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 11. 2012 S. 1134-1135
Heiberg, A.; Lampe, C.; Whiteman, D. A. H.
ENZYME REPLACEMENT THERAPY (ERT) IN MPS II PATIENTS AGED 20 YEARS OR OLDER AT TREATMENT INITIATION: DATA FROM THE HUNTER OUTCOME SURVEY (HOS)JOURNAL OF INHERITED METABOLIC DISEASE. Bd. 35. 2012 S. S88-S88
Beetz, R
Evaluation and management of urinary tract infections in the neonateCURRENT OPINION IN PEDIATRICS. Bd. 24. H. 2. 2012 S. 205-211
Langer, D; Bohne, F; Martine, U et al.
Evidence for a functional human network of imprinted genesEUROPEAN JOURNAL OF PEDIATRICS. Bd. 171. H. 9. 2012 S. 1425-1425
Ramaswami, U; Parini, R; Pintos-Morell, G et al.
Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome SurveyCLINICAL GENETICS. Bd. 81. H. 5. 2012 S. 485-490
Burmeister, S; Mildenberger, E; Whybra, C et al.
Falldarstellung: Präpartale Diagnose einer Mucolipidose Typ II mit IUFT in der 30. SSW [Abstract]Z Geburtsh Neonatol. Bd. 216. 2012 S. 83
Berner, R.; Boos, J.; Erdlenbruch, B. et al.
Free first Generation Antihistamine Prescription Position Paper of the Commission for Drug Safety in Children (KASK) of the German Society for Children and Adolescent Medicine (DGKJ)MONATSSCHRIFT KINDERHEILKUNDE. Bd. 160. H. 10. 2012 S. 992-+